| The Effect of?GTT-EGCG?on Acne Women | The Effect of?GTT-EGCG?on Acne Women | NCT01846338 |
| Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate | Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate | TCTR20200422001 |
| Effects of glutamine and epigallocatechin-3-gallate on glucose tolerance, markers of inflammation, oxidative stress and procoagulant status in Type 2 diabetes mellitus | Effects of glutamine and epigallocatechin-3-gallate on glucose tolerance, markers of inflammation, oxidative stress and procoagulant status in Type 2 diabetes mellitus - Glutamine and EGCG in type 2 diabetes mellitus | NL-OMON38189 |
| Improvement of Endothelial Function by EGCG | The Role of EGCG in Different Application Forms on Flow-mediated Dilation in Healthy Volunteers | NCT01662232 |
| Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis | A Phase II Open-label Randomized Study of Dietary Supplement With Epigallocatechin Gallate (EGCG) to Improve Cardiac Dysfunction in Patients With AL Amyloidosis Who do Not Require Chemotherapy (EpiCardiAL) | NCT01511263 |
| EGCG Improves Acne by Modulating Molecular Targets | Epigallocatechin-3-Gallate Improves Acne in Humans by Modulating Intracellular Molecular Targets and Inhibiting P. Acnes | NCT01687556 |
| Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect | Collagen-targeted PET Imaging for Assessment of EGCG Effect | NCT06265532 |
| SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy | SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy - SUNIMUD | EUCTR2009-016482-28-DE |
| Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults | Cerebral Blood Flow, Cerebro-electrical Activity and Behavioural Effects of Epigallocatechin Gallate (EGCG) Administration in Healthy, Young Adults | NCT00981292 |
| Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients | Dose Ranging Study of Oral Epigallocatechin-3-gallate (EGCG) Given Daily for 12 Weeks to Patients With Idiopathic Pulmonary Fibrosis (IPF) Evaluating Safety, PK Interactions With Standard of Care Drugs, and Biomarkers of Drug Effect | NCT05195918 |
| Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease - SUN-AK | Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease - SUN-AK | EUCTR2009-009656-20-DE |
| Sunphenon in Progressive Forms of Multiple Sclerosis | Monocentric, Prospective, Doubleblind, Randomised/Stratified, Placebocontrolled Two-arm Study to Evaluate the Effect of Sunphenon EGCg (Main Component Epigallocatechin-Gallat) on the Increase of Brain Atrophy in the Cerebral Magnetic Resonance Tomography in a 36-months Treatment Time in Patients With Primary or Secondary Chronic-progressive Multiple Sclerosis | NCT00799890 |
| Reducing Frailty for Older Cancer Survivors Using Supplements | Reducing Frailty for Older Cancer Survivors Using Supplements (ReFOCUS): A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer | NCT04553666 |
| Effect of EGCG on the Body's Response to Insulin | An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy and Obese Subjects | NCT00434499 |
| The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection. | A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection. | NCT06285357 |
| Pharmacokinetics and Hepatic Safety of EGCG | Pharmacokinetics and Hepatic Safety of EGCG | NCT04177693 |
| Skin Evaluation of Turmeric/EGCG Emulgel for Skin Irritation and Sensitization Effects in Healthy Participants | Skin Evaluation of Turmeric/EGCG Emulgel for Skin Irritation and Sensitization Effects in Healthy Participants | TCTR20250317007 |
| A phase III randomized controlled clinical trial of EGCG, a green tea extract, in the prevention of acute radiation-induced intestinal injury | A phase III randomized controlled clinical trial of EGCG, a green tea extract, in the prevention of acute radiation-induced intestinal injury | ChiCTR2500101198 |
| Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation | Effects of the Green Tea Extract TEAVIGO High in EGCG, on Postprandial Fat Oxidation in Overweight Volunteers | NCT00867555 |
| """Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome"" (TESFX)" | Estrogen Receptors Beta (ER-B) as Therapeutic Targets for the Improvement of Cognitive Performance in Fragile-X (TESXF) | NCT01855971 |
| Double blind, randomised, prospective placebo controlled parallel group phase III study to investigate the Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA) | Double blind, randomised, prospective placebo controlled parallel group phase III study to investigate the Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA) - Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach | EUCTR2012-000928-18-DE |
| Effect of Green Tea on Methadone Maintenance Patients | The effect of green tea enriched with EGCG on some inflammatory, antioxidant and cognitive factors in methadone maintenance patients; Triple-blind clinical trial | IRCT20180902040927N5 |
| A prospective phase II trial of EGCG for treatment of acute radiation-induced intestinal injury | A prospective phase II trial of EGCG for treatment of acute radiation-induced intestinal injury | ChiCTR2100053703 |
| Phase II clinical study of EGCG in preventing radiation oral mucositis | Phase II clinical study of EGCG in preventing radiation oral mucositis | ChiCTR2100052871 |
| Epigallocatechin as an immunomodulatory and antineoplastic treatment in elderly patients with acute leukemia or mielodysplasia | Epigallocatechin (EGCG) as an immunomodulatory and antineoplastic treatment in elderly patients with AML or high-risk MDS inelegible for high-dose conventional chemotherapy | RBR-3nvjx2k |
| Effect of Green Tea on Stroke | The effect of powdered green tea enriched with epigallocatechin gallate (EGCG) on some clinical, biochemical, inflammatory, antioxidant and cognitive parameters in stroke patients; a double-blind, placebo-controlled clinical trial | IRCT20180902040927N1 |
| Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis | Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis | NCT05116098 |
| Epigallocatechin-3-gallate (EGCG) in supportive and symptomatic treatment of patients with esophageal cancer | Epigallocatechin-3-gallate (EGCG) in supportive and symptomatic treatment of patients with esophageal cancer | ChiCTR2100050444 |
| The acute effects of a green tea extract, -Epigallocatechin Gallate (EGCG) on cognition, stress, brain function and cardiovascular function. | An investigation into the acute effects of -Epigallocatechin Gallate (EGCG) on cognition, stress, brain function and cardiovascular function in healthy adults. | ACTRN12609000646246 |
| Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer | Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer | NCT05039983 |
| Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients | Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients: Phase I-II Clinical Trial | NCT05758571 |
| The adjunctive use of (-)-epigallocatechin gallate (EGCG) subgingival irrigating solution with scaling and root planing in the management of chronic periodontitis | The adjunctive use of (-)-epigallocatechin gallate (EGCG) subgingival irrigating solution with scaling and root planing in the management of chronic periodontitis | ChiCTR2000029831 |
| Comparison of the tear level between (-)-epigallocatechin gallate (EGCG) and (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) after oral administration in healthy volunteers. | Comparison of the tear level between (-)-epigallocatechin gallate (EGCG) and (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) after oral administration in healthy volunteers. - Comparison of the tear level in green tea catechins after oral administration in healthy volunteers. | JPRN-UMIN000034291 |
| The effect of powdered green tea in patients with coronary artery disease | The effect of powdered green tea enriched with epigallocatchin gallate (EGCG) on some clinical, electrophysiological, biochemical, inflammatory and antioxidant parameters in patients with coronary artery disease, a randomized, triple blind clinical trial | IRCT20181203041835N1 |
| Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients | A Pilot Study to Evaluate the Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients with Curative Resections. | NCT02891538 |
| A randomized, blank controlled, open clinical study of EGCG in patients with non-alcoholic fatty liver disease | EGCG inhibits the interaction between DPP4 and PRDM10 to improve the occurrence and development of non-alcoholic fatty liver disease and its mechanism | ChiCTR2300076741 |
| Effect of the use of a catechin from green tea on the clinical performance of adhesives for dental restorations | Effect of epigallocatechin-3-gallate (EGCG) in the clinical performance of an universal adhesive system: a randomized clinical study. | RBR-2hr94r |
| Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy | | NCT02577393 |
| Effect of a Green Tea's Catechin on Appetite in healthy women | Effects of Acute Supplementation with Epigalocatequine 3 Galate (EGCG) on Appetite's Modulation in healthy women | RBR-9svwrv |
| Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy | Phase II Study of Topical Epigallocatechin-3-gallate (EGCG) in Patients With Breast Cancer Receiving Adjuvant Radiotherapy | NCT02580279 |
| Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention | Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention | NCT03978052 |
| Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS) | Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS) | NCT03624556 |
| Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary Pneumonia | Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary:Phase II Clinical Trial | NCT06924749 |
| Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance | A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin Gallate Supplementation on Serum Brain Derived Neurotrophic Factor and Mood Disturbance in Adults | NCT06531863 |
| Reducing Frailty for Older Cancer Survivors Using Supplements II | A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer | NCT06068543 |
| Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children | Epigallocatechin Gallate (EGCG) as Therapeutic Tool to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children | NCT02558933 |
| Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer | A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG | NCT00666562 |
| Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients | Study of Epstein-Barr Virus Reactivation and the Effect of Dietary Supplement Epigallocatechin Gallate (EGCG) on Virus Reactivation in Remission Patients With Nasopharyngeal Carcinoma - A Randomized Trial | NCT01744587 |
| Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals. | Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals. | NCT01394796 |
| Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington | Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington - ETON | EUCTR2010-023941-31-DE |
| Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy | Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy | NCT01183767 |
| Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease | Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease | NCT00951834 |
| Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) | Single-site, Open-label, Dose-ranging, Efficacy, and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated CF | NCT00889434 |
| Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection | Evaluation of Oral Epigallocatechin Gallate Treatment for Low-grade Cervical Lesions (L-SIL) Associated With Human Papilloma Virus (HPV) Infection | NCT06314113 |
| Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis | The Influence of Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy Using Two Different Calcium Silicate-based Materials on Postoperative Pain and Success Rate in Mature Permanent Molars With Irreversible Pulpitis: A Randomized Clinical Trial | NCT05811403 |
| EGCG for the Prevention and Treatment of TIPN | Clinical Study of EGCG for the Prevention and Treatment of Peripheral Neuropathy Induced by Taxane (TIPN) | NCT06524609 |
| Comparative Evaluation of Nanohydroxyapatite & EGCG mix versus Biodentine for Indirect Pulp Therapy in Young Permanent Teeth | Comparative Evaluation Of Indirect Pulp Therapy In Young Permanent Teeth Using Nanohydroxyapatite And Epigallocatechin-3-Gallate (EGCG) Mix Versus Biodentine: A Randomized Controlled Trial - NIL | CTRI/2025/03/082145 |
| EGCG for Hepatocellular Carcinoma Chemoprevention | Phase II Randomized Controlled Trial of Epigallocatechin Gallate for Hepatocellular Carcinoma Chemoprevention | NCT06015022 |
| Efficacy of a maintenance therapy with supplements containing indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) in ovarian cancer patients | An open randomized controlled clinical trial to evaluate the efficacy of a maintenance therapy with supplements containing I3C and EGCG in ovarian cancer patients | ACTRN12616000394448 |
| Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma | The Clinical and Biologic Evaluation of Polyphenon E, an Extract of Green Tea Containing EGCG, in Plasma Cell Dyscrasias - Pilot Study | NCT00942422 |
